Lund, Switzerland

Per O Kimblad

This inventor holds 1 USPTO granted patent. Top assignee: Edwards Lifesciences Ag. Active years: 2007.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Per O Kimblad

Introduction

Per O Kimblad is a notable inventor based in Lund, Switzerland. He has made significant contributions to the field of medical devices, particularly in the treatment of mitral insufficiency. His innovative approach has led to the development of a unique device that addresses a critical health issue.

Latest Patents

Per O Kimblad holds a patent for a "Method and device for treatment of mitral insufficiency." This device is designed to treat mitral annulus dilatation and features an elongate body that can transition between two states. In its first state, the elongate body is insertable into the coronary sinus, adapting to its shape. Once positioned, it can be transferred to a second state, reducing the radius of curvature of both the coronary sinus and the mitral annulus, thereby improving patient outcomes.

Career Highlights

Throughout his career, Per O Kimblad has been associated with Edwards Lifesciences AG, a company renowned for its focus on innovative heart valve therapies and critical care monitoring. His work has contributed to advancements in medical technology, particularly in cardiac care.

Collaborations

Per O Kimblad has collaborated with esteemed colleagues such as Jan Otto Solem and Erwin Berger. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge medical solutions.

Conclusion

Per O Kimblad's contributions to the field of medical devices, particularly through his patent for treating mitral insufficiency, highlight his role as a significant innovator in healthcare. His work continues to impact the lives of patients and advance medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…